Literature DB >> 17280647

Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.

Mia Thompson1, Simone Lauderdale, Maree J Webster, Victor Z Chong, Benjamin McClintock, Richard Saunders, Cynthia Shannon Weickert.   

Abstract

Neuregulin (NRG) signaling proteins interact with ErbB receptors leading to the proliferation, differentiation and migration of neurons and glia in the developing brain. NRG-1/ErbB4 are susceptibility genes for schizophrenia, yet little is known about the neuroanatomical expression of ErbB receptors specifically in primates. We find widespread expression of ErbB2, ErbB3 and ErbB4 receptor mRNAs throughout the telencephalon of juvenile and adult monkeys with in situ hybridization, with ErbB2 and ErbB4 mRNA more abundant than ErbB3 mRNA. ErbB2 and ErbB4 mRNA are expressed at higher levels in grey matter compared to white matter, whereas ErbB3 mRNA is expressed at low levels in both grey and white matter. We also characterized ErbB protein expression with immunoblotting and immunohistochemistry. In frontal cortex, ErbB2, ErbB3 and ErbB4 antibodies immunostained neuronal soma and nuclei. The ErbB2 antibody also immunostained glia at the pial surface. Within white matter, ErbB3 and ErbB4 proteins were localized to putative interstitial white matter neurons while ErbB2 protein was found in glia. Western blotting revealed immunopositive bands at approximately 180-200 kDa for each ErbB, which is consistent with the size of full-length ErbBs. Smaller immunopositive bands were also identified for each ErbB receptor in whole brain homogenates and separate cytoplasmic and nuclear extracts suggesting nuclear ErbB-back-signaling capacity in the brain. The ubiquitous expression of ErbB receptors indicates that many cell populations throughout the brain of juvenile and adult primates have the potential to respond to NRG-1 in a variety of ways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280647     DOI: 10.1016/j.brainres.2006.11.047

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

1.  Bone morphogenetic proteins regulate enteric gliogenesis by modulating ErbB3 signaling.

Authors:  Alcmène Chalazonitis; Fabien D'Autréaux; Tuan D Pham; John A Kessler; Michael D Gershon
Journal:  Dev Biol       Date:  2010-11-19       Impact factor: 3.582

Review 2.  Nuclear trafficking of the epidermal growth factor receptor family membrane proteins.

Authors:  Y-N Wang; H Yamaguchi; J-M Hsu; M-C Hung
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

Review 3.  Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders.

Authors:  Peter Penzes; Andres Buonanno; Maria Passafaro; Carlo Sala; Robert A Sweet
Journal:  J Neurochem       Date:  2013-05-22       Impact factor: 5.372

Review 4.  The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.

Authors:  Andrés Buonanno
Journal:  Brain Res Bull       Date:  2010-08-03       Impact factor: 4.077

5.  Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia.

Authors:  Jörg Neddens; Kenneth N Fish; Ludovic Tricoire; Detlef Vullhorst; Alon Shamir; Wonjae Chung; David A Lewis; Chris J McBain; Andrés Buonanno
Journal:  Biol Psychiatry       Date:  2011-06-12       Impact factor: 13.382

6.  ErbB4 localization to interneurons: clearer insights into schizophrenia pathology.

Authors:  Margaret A Cooper; Anthony J Koleske
Journal:  Biol Psychiatry       Date:  2011-10-01       Impact factor: 13.382

7.  A nuclear variant of ErbB3 receptor tyrosine kinase regulates ezrin distribution and Schwann cell myelination.

Authors:  Tadepalli Adilakshmi; Jennifer Ness-Myers; Carlos Madrid-Aliste; Andras Fiser; Nikos Tapinos
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

Review 8.  Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders.

Authors:  R Gao; P Penzes
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

Review 9.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

Review 10.  Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors.

Authors:  Shao-Chun Wang; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.